Artal Group’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-200,000
Closed -$9.07M 104
2017
Q3
$9.07M Buy
200,000
+50,000
+33% +$2.27M 0.16% 26
2017
Q2
$5.06M Sell
150,000
-50,000
-25% -$1.69M 0.09% 39
2017
Q1
$5.92M Hold
200,000
0.13% 37
2016
Q4
$5.49M Hold
200,000
0.12% 27
2016
Q3
$12.3M Buy
+200,000
New +$12.3M 0.24% 16
2016
Q2
Hold
0
64
2016
Q1
Hold
0
57
2015
Q4
Hold
0
66